Detalhe da pesquisa
1.
Inhibition of proprotein convertases abrogates processing of the middle eastern respiratory syndrome coronavirus spike protein in infected cells but does not reduce viral infectivity.
J Infect Dis
; 211(6): 889-97, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25057042
2.
TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
J Virol
; 88(2): 1293-307, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24227843
3.
TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium.
J Virol
; 87(11): 6150-60, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23536651
4.
The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies.
J Virol
; 87(10): 5502-11, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23468491
5.
Chlamydia psittaci inclusion membrane protein IncB associates with host protein Snapin.
Int J Med Microbiol
; 304(5-6): 542-53, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24751478
6.
Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.
Antiviral Res
; 100(3): 605-14, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24121034
7.
Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts.
PLoS One
; 7(4): e35876, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22558251